Zhao-Wu Zeng (Zhaowu Zeng)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Binding Protein

Hyaluronic Acid

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhao-Wu Zeng, Xianglong Zeng, Xinyi Li, Yuxin Feng, Yue Kan, Xingyan Liu, Yi-Ying Zeng
The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer. Pharmaceutics 16 (1) (2024)
Zhao-Wu Zeng, Xianglong Zeng, Xinyi Li, Yuxin Feng, Yue Kan, Xingyan Liu, Yi-Ying Zeng
The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer. Pharmaceutics 16 (1) (2024)
Zhao-Wu Zeng, Xianglong Zeng, Xinyi Li, Yuxin Feng, Yue Kan, Xingyan Liu, Yi-Ying Zeng
The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer. Pharmaceutics 16 (1) (2024)
Tiantian Tan, Jie Li, Ruhua Luo, Rongrong Wang, Liyan Yin, Mengmeng Liu, Yi-Ying Zeng, Zhao-Wu Zeng, Tian Xie
Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review. Molecules (Basel, Switzerland) 26 (19) (2021)
Yi-Ying Zeng, Yi-Jun Zeng, Na-Na Zhang, Chen-Xi Li, Tian Xie, Zhao-Wu Zeng
The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma. Molecules (Basel, Switzerland) 24 (9) (2019)